… transformative RNA therapies based on its proprietary Axiomer ™ RNA editing technology platform today announced … will then be available for approximately 30 days. About Axiomer ™ ProQR is pioneering a next-generation RNA base editing technology called Axiomer ™ , which could potentially yield a new class of …
… Our leading intellectual property portfolio protects our Axiomer ® ADAR-mediated RNA editing platform technology and … patent protection related to its RNA editing platform, Axiomer ® , including more than 11 published patent families, … its IP estate around ADAR-mediated RNA editing. About Axiomer ® ProQR is pioneering a next-generation RNA base …
… transformative RNA therapies based on its proprietary Axiomer ® RNA editing technology platform, today reported its … pleased with the continued progress in advancing our Axiomer ® RNA editing platform and believe we’re only at the … In November ProQR announced its IP estate surrounding its Axiomer ® RNA editing platform was further strengthened by: …
… the event, the Company will showcase its proprietary Axiomer ® RNA-editing technology platform, announce initial … and mentored over 50 Ph.D. and M.S. degree students. About Axiomer ® ProQR is pioneering a next-generation RNA base editing technology called Axiomer ® , which could potentially yield a new class of …
… An innovative biotech company advancing our proprietary Axiomer RNA-editing platform technology. We are ProQR We are … and common diseases. We focus on advancing our proprietary Axiomer™ RNA-editing platform technology. ProQR has offices …
… treatments for people with rare genetic diseases. Axiomer RNA base editing At ProQR we invented the Axiomer™ technology that enables single base editing to …
… and families affected by rare and common disorders using Axiomer, our innovative RNA editing platform technology. At … and families affected by rare and common disorders using Axiomer, our innovative RNA editing platform technology. …
… At our offices in Leiden we are advancing our proprietary Axiomer RNA-editing platform technology. Our ProQRians, … USA. ProQR is focused on advancing its proprietary Axiomer™ RNA-editing platform technology to develop life …
… Announces Year End 2024 Operating and Financial Results Axiomer™ ADAR-mediated RNA editing pipeline advancing across … transformative RNA therapies based on its proprietary Axiomer RNA editing technology platform, today reported its …
